Thomas Watkins - Net Worth and Insider Trading

Thomas Watkins Net Worth

The estimated net worth of Thomas Watkins is at least $2 Million dollars as of 2024-04-26. Thomas Watkins is the Director of Horizon Therapeutics PLC and owns about 16,000 shares of Horizon Therapeutics PLC (HZNP) stock worth over $2 Million. Thomas Watkins is also the Director of Vanda Pharmaceuticals Inc and owns about 63,064 shares of Vanda Pharmaceuticals Inc (VNDA) stock worth over $282,527. Details can be seen in Thomas Watkins's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas Watkins has not made any transactions after 2022-06-02 and currently still holds the listed stock(s).

Transaction Summary of Thomas Watkins

To

Thomas Watkins Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas Watkins owns 2 companies in total, including Vanda Pharmaceuticals Inc (VNDA) , and Horizon Therapeutics PLC (HZNP) .

Click here to see the complete history of Thomas Watkins’s form 4 insider trades.

Insider Ownership Summary of Thomas Watkins

Ticker Comapny Transaction Date Type of Owner
VNDA Vanda Pharmaceuticals Inc 2022-06-02 director
HZNP Horizon Therapeutics PLC 2015-08-19 director

Thomas Watkins Latest Holdings Summary

Thomas Watkins currently owns a total of 2 stocks. Among these stocks, Thomas Watkins owns 16,000 shares of Horizon Therapeutics PLC (HZNP) as of August 19, 2015, with a value of $2 Million and a weighting of 86.82%. Thomas Watkins also owns 63,064 shares of Vanda Pharmaceuticals Inc (VNDA) as of June 2, 2022, with a value of $282,527 and a weighting of 13.18%.

Latest Holdings of Thomas Watkins

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HZNP Horizon Therapeutics PLC 2015-08-19 16,000 116.30 1,860,800
VNDA Vanda Pharmaceuticals Inc 2022-06-02 63,064 4.48 282,527

Holding Weightings of Thomas Watkins


Thomas Watkins Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas Watkins has made a total of 0 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years. The most-recent trade in Horizon Therapeutics PLC is the acquisition of 10,000 shares on August 19, 2015, which cost Thomas Watkins around $313,200.

According to the SEC Form 4 filings, Thomas Watkins has made a total of 3 transactions in Vanda Pharmaceuticals Inc (VNDA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Vanda Pharmaceuticals Inc is the sale of 6,441 shares on June 2, 2022, which brought Thomas Watkins around $63,766.

Insider Trading History of Thomas Watkins

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas Watkins Trading Performance

GuruFocus tracks the stock performance after each of Thomas Watkins's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas Watkins is -39.81%. GuruFocus also compares Thomas Watkins's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas Watkins within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Thomas Watkins's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Thomas Watkins

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.08 -39.81 -41.57 -26.96 -34.76 -13.04
Relative Return to S&P 500(%) 7.93 -39.89 -33.79 -31.96 -42.76 -24.13

Thomas Watkins Ownership Network

Ownership Network List of Thomas Watkins

No Data

Ownership Network Relation of Thomas Watkins


Thomas Watkins Owned Company Details

What does Vanda Pharmaceuticals Inc do?

Who are the key executives at Vanda Pharmaceuticals Inc?

Thomas Watkins is the director of Vanda Pharmaceuticals Inc. Other key executives at Vanda Pharmaceuticals Inc include director & Chief Executive Officer Mihael Hristos Polymeropoulos , SVP & General Counsel Timothy Williams , and SVP & Business Development Gunther Birznieks .

Vanda Pharmaceuticals Inc (VNDA) Insider Trades Summary

Over the past 18 months, Thomas Watkins made no insider transaction in Vanda Pharmaceuticals Inc (VNDA). Other recent insider transactions involving Vanda Pharmaceuticals Inc (VNDA) include a net sale of 51,638 shares made by Kevin Patrick Moran , a net sale of 56,426 shares made by Timothy Williams , and a net sale of 196,036 shares made by Mihael Hristos Polymeropoulos .

In summary, during the past 3 months, insiders sold 121,098 shares of Vanda Pharmaceuticals Inc (VNDA) in total and bought 0 shares, with a net sale of 121,098 shares. During the past 18 months, 377,072 shares of Vanda Pharmaceuticals Inc (VNDA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 377,072 shares.

Vanda Pharmaceuticals Inc (VNDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vanda Pharmaceuticals Inc Insider Transactions

No Available Data

Thomas Watkins Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas Watkins. You might contact Thomas Watkins via mailing address: 1221 Gulf Shore Blvd N #303, Naples Fl 34102.

Discussions on Thomas Watkins

No discussions yet.